Mirum Pharmaceuticals, Inc. provided sales guidance for the year 2024. The company expects net product sales to be $310 million to $320 million for 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.25 USD | -2.25% | -2.21% | -14.40% |
05-08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Mirum Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.40% | 1.22B | |
+19.88% | 47.02B | |
+49.28% | 41.86B | |
+0.22% | 41.76B | |
-4.27% | 28.8B | |
+11.87% | 26.05B | |
-22.20% | 19.15B | |
+4.38% | 12.55B | |
+28.68% | 12.34B | |
-4.09% | 11.82B |
- Stock Market
- Equities
- MIRM Stock
- News Mirum Pharmaceuticals, Inc.
- Mirum Pharmaceuticals, Inc. Provides Sales Guidance for the Year 2024